Susan Hasty, Publisher
Table of Contents . . . April 26th, 1999Non-Subscriber - Summaries Only
Therapy (HCV) - Phase I/II Study Shows rHuIL-12 Not Effective
Coinfection - HGV Doesn't Impact IFN Efficacy
Disease Course - HCV Transmitted by IV Drug Evaluated
Genotyping - Lymphoid A/F Linked to HCV 1b and Inflammation
Immunology - Two Dose HBV Vaccine Shown to be Effective
Occupational Exposure - Biomedical Workers Not at Increased Risk for HAV
Risk Factors - Alcohol More Important than HCV in Liver Death
Viral Clearance - HBsAg Clearance in Transplant Patients Described
Virology - Hepadnavirus Polymerases Studied
Blood Safety (Screening) - Hepatitis C Screening Procedure Gains IND Approval
Industry News (HBV Therapies) - Data Presented on Drug Effective Against Resistant HBV
Industry News (HBV Therapy) - Lamivudine Promises Long-Term Benefits for Chronic Hepatitis B Sufferers
Pathogenesis (HCV) - "Gene Expression and Replication of Hepatitis C Virus."
Hepatitis Vaccination - "Engerix B Vaccination in Children with Malignant Diseases."
Duck Hepatitis B Virus - "Residues Critical for Duck Hepatitis B Virus Neutralization Are Involved in Host Cell Interaction."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.